Page 7 - அமெரிக்கன் சங்கம் க்கு புற்றுநோய் ஆராய்ச்சி ஆண்டு சந்தித்தல் News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Mitazalimab synergizes with chemotherapy - Alligator Bioscience presents new preclinical data at AACR Alligator Bioscience (Nasdaq Stockholm: ATORX) today announced that an abstract for a poster presentation at the AACR (American Association for Cancer Research) Annual Meeting 2021, presenting new preclinical data for the clinical asset mitazalimab, is now released. The AACR Annual Meeting 2021 will be held in a virtual format over two one-week periods in April and May 2021. Alligator Bioscience s abstract will be presented in an ePoster session during April 10-15. Alligator Bioscience has previously shown that mitazalimab synergizes effectively with immune checkpoint inhibitors and vaccines. The abstract, titled Mitazalimab, a potent CD40 agonist with potential for combination with chemotherapy , demonstrates that mitazalimab synergizes with chemotherapy, notably FOLFIRINOX, leading to improved long-term survival in a preclinical tumor model.

United statesAmerican association for cancer research annual meetingAptevo therapeutics incShanghai henlius biotech incNasdaq stockholmAmerican associationCancer researchAnnual meetingPer norlAptevo therapeuticsShanghai henlius biotechஒன்றுபட்டது மாநிலங்களில்அமெரிக்கன் சங்கம் க்கு புற்றுநோய் ஆராய்ச்சி ஆண்டு சந்தித்தல்நாஸ்டாக் ஸ்டாக்‌ஹோல்ம்அமெரிக்கன் சங்கம்புற்றுநோய் ஆராய்ச்சி